Pulmonary Embolism in Patients with Covid-19 in Direct Oral Anticoagulant
Authors:
- Fabio Augusto De LucaFLFabio Augusto De Luca
- Guilherme ArrudaGAGuilherme Arruda
- Vinicius EstevesVEVinicius Esteves
- André FeldmanAFAndré Feldman
- Ítalo Bruno dos Santos SousaÍSÍtalo Bruno dos Santos Sousa
- José Célio Vieira BrandãoJBJosé Célio Vieira Brandão
- Raquel Muarrek GarciaRGRaquel Muarrek Garcia
- Olga Ferreira de SouzaOSOlga Ferreira de Souza
- 15 January 2021
- journal article
- research article
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
Abstract
Introduction The global pandemic caused by the new coronavirus (COVID-19) has been promoting major challenges and unprecedented clinical decisions in the medical scenario. Currently, according to the World Health Organization, the disease affects over 185 countries, with over 12 million people infected and nearly 500 thousand deaths. Among the most serious manifestations of the syndrome, the high prevalence of thromboembolic events, up to 31% of the patients hospitalized in intensive care units, according to an international series, calls attention.– Different [...] Introduction The global pandemic caused by the new coronavirus (COVID-19) has been promoting major challenges and unprecedented clinical decisions in the medical scenario. Currently, according to the World Health Organization, the disease affects over 185 countries, with over 12 million people infected and nearly 500 thousand deaths. Among the most serious manifestations of the syndrome, the high prevalence of thromboembolic events, up to 31% of the patients hospitalized in intensive care units, according to an international series, calls attention.– DifferentKeywords
This publication has 14 references indexed in Scilit:
- Acute Pulmonary Embolism and COVID-19Radiology, 2020
- COVID-19 and its implications for thrombosis and anticoagulationBlood, 2020
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpJACC, 2020
- COVID-19: progression of disease and intravascular coagulation – present status and future perspectivesClinical Chemistry and Laboratory Medicine (CCLM), 2020
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Incidence of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort studyIntensive Care Medicine, 2020
- Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelinesJournal of Thrombosis and Thrombolysis, 2020
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Acute pulmonary embolism and COVID-19 pneumonia: a random association?European Heart Journal, 2020